A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
Kindler, H.L., Richards, D.A., Garbo, L.E., Garon, E.B., Stephenson, J.J., Rocha-Lima, C.M., Safran, H., Chan, D., Kocs, D.M., Galimi, F., McGreivy, J., Bray, S.L., Hei, Y., Feigal, E.G., Loh, E., Fuchs, C.S.
Published in Annals of oncology (01.11.2012)
Published in Annals of oncology (01.11.2012)
Get full text
Journal Article
A placebo-controlled, randomized phase II study of conatumumab (C) or AMG 479 (A) or placebo (P) plus gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (mPC)
Kindler, H. L., Richards, D. A., Stephenson, J., Garbo, L. E., Rocha Lima, C. S., Safran, H., Wiezorek, J. S., Feigal, E. G., Bray, S., Fuchs, C.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
An open label phase I dose escalation study of ADH-1 in combination with chemotherapy in subjects with N-Cadherin expressing solid tumors
Raju, R. N., Alemany, C., Basche, M., Garbo, L. E., Richards, D. A., Smith, D. A., Stephenson, J. J., Norris, R., Lawton, M., Peters, W., Becerra, C. R.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Phase II multicenter, two-stage study of E7389 in patients with hormone refractory prostate cancer with advanced and/or metastatic disease stratified by prior chemotherapy
Molife, R., Cartwright, T. H., Loesch, D. M., Garbo, L. E., Sonpavde, G., Calvo, E., Das, A., Wanders, J., Petrylak, D. P., de Bono, J.
Published in Journal of clinical oncology (20.06.2007)
Published in Journal of clinical oncology (20.06.2007)
Get full text
Journal Article
Azacitidine for castration-resistant prostate cancer progressing on combined androgen blockade
Sonpavde, G., Aparicio, A. M., Delaune, R., Garbo, L. E., Rousey, S. R., Weinstein, R. E., Williams, A., Zhan, F., Boehm, K. A., Asmar, L., Von Hoff, D. D.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
Kindler, H L, Richards, D A, Garbo, L E, Garon, E B, Stephenson, Jr, J J, Rocha-Lima, C M, Safran, H, Chan, D, Kocs, D M, Galimi, F, McGreivy, J, Bray, S L, Hei, Y, Feigal, E G, Loh, E, Fuchs, C S
Published in Annals of oncology (01.11.2012)
Get full text
Published in Annals of oncology (01.11.2012)
Journal Article